Artbio Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
74
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$132M
- Investors
-
11
Artbio General Information
Description
Operator of a radiopharmaceutical company intended to offer a new approach to the treatment of cancer. The company specializes in radioligand therapy, which delivers alpha or beta emitters to break down cancer cell DNA and build an ecosystem that maximizes the potential of the therapy, enabling medical practitioners to utilize novel mechanisms in oncology.
Contact Information
Website
www.artbio.comCorporate Office
- One Kendall Square, B200
- Suite 001
- Cambridge, MA 02139
- United States
Corporate Office
- One Kendall Square, B200
- Suite 001
- Cambridge, MA 02139
- United States
Artbio Timeline
Artbio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series B) | 29-Jul-2025 | $132M | Completed | Clinical Trials - Phase 1 | ||
| 2. Early Stage VC (Series A) | 07-Dec-2023 | Completed | Pre-Clinical Trials | |||
| 1. Seed Round | 21-Jun-2023 | $23M | $23M | Completed | Pre-Clinical Trials |
Artbio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed-1 | ||||||||
| Seed | 11,148,808 | $0.000010 | $2.1 | $2.1 | 1x | $2.1 | 21.07% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Artbio Comparisons
Industry
Financing
Details
Artbio Competitors (42)
One of Artbio’s 42 competitors is CytomX Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Radionetics Oncology | Venture Capital-Backed | Menlo Park, CA | ||||
| ExCellThera | Accelerator/Incubator Backed | Montreal, Canada | ||||
| RadioMedix | Venture Capital-Backed | Houston, TX | ||||
| Navidea Biopharmaceuticals | Corporate Backed or Acquired | Columbus, OH |
Artbio Patents
Artbio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026226835-A1 | Integrin targeting radiotherapeutic compositions and uses thereof | Pending | 23-Apr-2025 | ||
| WO-2026207185-A1 | Gaseous emanation radionuclide generators and methods including environmental control | Pending | 26-Mar-2025 | ||
| AU-2025268764-A1 | Radionuclide source holders and methods of operation | Pending | 07-May-2024 | ||
| WO-2025235562-A1 | Radionuclide source holders and methods of operation | Pending | 07-May-2024 | ||
| AU-2025247169-A1 | Radionuclide source clip attachment system | Pending | 29-Mar-2024 | A61N5/1007 |
Artbio Signals
Artbio Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alexandria Venture Investments | Venture Capital | Minority | ||
| B Capital Group | Venture Capital | Minority | ||
| Bow River Capital | PE/Buyout | Minority | ||
| Qatar Investment Authority | Sovereign Wealth Fund | Minority | ||
| Baker Brothers Investments | Hedge Fund | Minority |
Artbio FAQs
-
When was Artbio founded?
Artbio was founded in 2021.
-
Where is Artbio headquartered?
Artbio is headquartered in Cambridge, MA.
-
What is the size of Artbio?
Artbio has 74 total employees.
-
What industry is Artbio in?
Artbio’s primary industry is Drug Discovery.
-
Is Artbio a private or public company?
Artbio is a Private company.
-
What is Artbio’s current revenue?
The current revenue for Artbio is .
-
How much funding has Artbio raised over time?
Artbio has raised $245M.
-
Who are Artbio’s investors?
Alexandria Venture Investments, B Capital Group, Bow River Capital, Qatar Investment Authority, and Baker Brothers Investments are 5 of 11 investors who have invested in Artbio.
-
Who are Artbio’s competitors?
CytomX Therapeutics, Radionetics Oncology, ExCellThera, RadioMedix, and Navidea Biopharmaceuticals are some of the 42 competitors of Artbio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process